HUP0002291A3 - Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action - Google Patents

Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action

Info

Publication number
HUP0002291A3
HUP0002291A3 HU0002291A HUP0002291A HUP0002291A3 HU P0002291 A3 HUP0002291 A3 HU P0002291A3 HU 0002291 A HU0002291 A HU 0002291A HU P0002291 A HUP0002291 A HU P0002291A HU P0002291 A3 HUP0002291 A3 HU P0002291A3
Authority
HU
Hungary
Prior art keywords
pyrrolothiazine
alpha1
serotonin
blocking action
receptor antagonistic
Prior art date
Application number
HU0002291A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Publication of HUP0002291A2 publication Critical patent/HUP0002291A2/hu
Publication of HUP0002291A3 publication Critical patent/HUP0002291A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU0002291A 1997-12-26 1998-12-25 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action HUP0002291A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9366756A JPH11193289A (ja) 1997-12-26 1997-12-26 ピロールスルホンアミド誘導体
PCT/JP1998/005954 WO1999033840A2 (en) 1997-12-26 1998-12-25 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action

Publications (2)

Publication Number Publication Date
HUP0002291A2 HUP0002291A2 (hu) 2001-04-28
HUP0002291A3 true HUP0002291A3 (en) 2002-12-28

Family

ID=18487593

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002291A HUP0002291A3 (en) 1997-12-26 1998-12-25 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action

Country Status (9)

Country Link
US (3) US6271223B1 (enExample)
EP (1) EP0970088A2 (enExample)
JP (1) JPH11193289A (enExample)
KR (1) KR20000075641A (enExample)
CN (2) CN1148372C (enExample)
AU (1) AU752095B2 (enExample)
CA (1) CA2282458A1 (enExample)
HU (1) HUP0002291A3 (enExample)
WO (1) WO1999033840A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020845A1 (fr) 1995-12-01 1997-06-12 Suntory Limited Derives de pyrroloazepine
JPH11193290A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
AU784462B2 (en) * 2000-03-31 2006-04-06 Purdue Research Foundation Phosphoramidate prodrugs
IL283725B2 (en) 2017-06-20 2024-04-01 Imbria Pharmaceuticals Inc Compositions and methods for increasing efficiency of cardiac metabolism
WO2020081361A1 (en) 2018-10-17 2020-04-23 Imbria Pharmaceuticals, Inc. Methods of treating rheumatic diseases using trimetazidine-based compounds
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US240178A (en) 1881-04-12 Feeding device for button-hole sewing-machines
US208631A (en) 1878-10-01 Improvement in trimmers for wax-thread sewing-machines
US236765A (en) 1881-01-18 Attoenet
JP3198117B2 (ja) 1990-02-07 2001-08-13 サントリー株式会社 ピロロアゼピン誘導体
US5075440A (en) 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
FR2675802B1 (fr) * 1991-04-26 1993-12-24 Rhone Poulenc Rorer Sa Antiserotonines, leur preparation et les medicaments les contenant.
WO1993003032A1 (fr) 1991-08-07 1993-02-18 Suntory Limited Compose de pyrroloazepine
CA2093631C (en) 1991-08-07 2003-09-23 Akira Mizuno Pyrroloazepine derivative
IL108634A0 (en) * 1993-02-15 1994-05-30 Wellcome Found Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
AU690622B2 (en) * 1993-12-24 1998-04-30 Daiichi Suntory Pharma Co., Ltd Benzothiazine derivative
DE69630184T2 (de) 1995-11-02 2004-08-12 Daiichi Suntory Pharma Co., Ltd. Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten
WO1997020845A1 (fr) 1995-12-01 1997-06-12 Suntory Limited Derives de pyrroloazepine
JPH10251258A (ja) 1997-03-14 1998-09-22 Suntory Ltd ピロロアゼピン系化合物
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
JPH11193290A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物

Also Published As

Publication number Publication date
US7057036B2 (en) 2006-06-06
CN1282643C (zh) 2006-11-01
CA2282458A1 (en) 1999-07-08
KR20000075641A (ko) 2000-12-26
US20020040017A1 (en) 2002-04-04
CN1260798A (zh) 2000-07-19
WO1999033840B1 (en) 1999-10-14
US6271223B1 (en) 2001-08-07
AU1690699A (en) 1999-07-19
AU752095B2 (en) 2002-09-05
US6624314B2 (en) 2003-09-23
CN1528746A (zh) 2004-09-15
WO1999033840A3 (en) 1999-09-10
CN1148372C (zh) 2004-05-05
US20050038242A2 (en) 2005-02-17
EP0970088A2 (en) 2000-01-12
WO1999033840A2 (en) 1999-07-08
US20040127705A1 (en) 2004-07-01
JPH11193289A (ja) 1999-07-21
HUP0002291A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
GB2323423B (en) Dampers
EP0967665A4 (en) THERMOELECTRIC CONVERTER
GB2323821B (en) Foldable push-chair
PL335999A1 (en) Substituted 3-cyanoquinolines
AP2000001795A0 (en) Substituted 4-aminothiazol-2-yol
AU138722S (en) Backpack
PL339413A1 (en) Antagonistic vitronectin receptor
PL339414A1 (en) Antagonistic vitronectin receptor
IL133920A0 (en) Trail receptor
GB9702354D0 (en) Compounds and their use
TW418650U (en) Mat
HUP0002291A3 (en) Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action
EP1039709A4 (en) RECEIVER
TW349616U (en) Damper
EP0968655A4 (en) SPREAD
IL130180A0 (en) Substituted pyrimidine compounds and their use
GB9720891D0 (en) Agrochemical compositions
PL334546A1 (en) Substituted 4-benzoylpyrazoles
TW337320U (en) Damper
ZA988492B (en) Substituted tetrahydro-naphthalenes and analogous compounds
GB9822575D0 (en) Construction fitting
GB9821760D0 (en) Framelock component
GB9727043D0 (en) Camera hammock
IL133261A0 (en) Substituted naphthropyrans
ZA985761B (en) Substituted aryluracils

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ASUBIO PHARMA CO., LTD., JP

Free format text: FORMER OWNER(S): DAIICHI ASUBIO PHARMA CO., LTD., JP; DAIICHI SUNTORY PHARMA CO., LTD., JP; SUNTORY LIMITED, JP

FD9A Lapse of provisional protection due to non-payment of fees